Cargando…
Amelioration of myocardial ischemia/reperfusion injury in diabetes: A narrative review of the mechanisms and clinical applications of dexmedetomidine
Mechanisms contributing to the pathogenesis of myocardial ischemia-reperfusion (I/R) injury are complex and multifactorial. Many strategies have been developed to ameliorate myocardial I/R injuries based on these mechanisms. However, the cardioprotective effects of these strategies appear to diminis...
Autores principales: | Sun, Meng, Wang, Rong, Xia, Rui, Xia, Zhengyuan, Wu, Zhilin, Wang, Tingting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470922/ https://www.ncbi.nlm.nih.gov/pubmed/36120296 http://dx.doi.org/10.3389/fphar.2022.949754 |
Ejemplares similares
-
Dexmedetomidine preconditioning ameliorates kidney ischemia-reperfusion injury
por: Lempiäinen, Juha, et al.
Publicado: (2014) -
Myocardial ischemia/reperfusion injury: Mechanisms of injury and implications for management (Review)
por: He, Jianfeng, et al.
Publicado: (2022) -
Downregulation of cardiac PIASy inhibits Cx43 SUMOylation and ameliorates ventricular arrhythmias in a rat model of myocardial ischemia/reperfusion injury
por: Wang, Tingting, et al.
Publicado: (2023) -
Evolving spectrum of dexmedetomidine preconditioning for Ischemia–reperfusion injury amelioration
por: Kohli, Jasvinder K., et al.
Publicado: (2020) -
Natural Compound Library Screening Identifies Oroxin A for the Treatment of Myocardial Ischemia/Reperfusion Injury
por: Cheng, Xingdong, et al.
Publicado: (2022)